Form 4/A for IMUX IMMUNIC, INC.
Accepted 2025-06-20 00:00:00 ET · period of report 2025-06-04 · accession 0001193805-25-000923 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| DA | 2025-06-20 | 2025-06-04 | IMUX | Vitt Daniel | CEO, Dir | P - Purchase | $0.77 | +15.0K | 29.0K | +107% | +$11.6K |
| DA | 2025-06-20 | 2025-06-05 | IMUX | Vitt Daniel | CEO, Dir | A - Grant | $0.00 | +1.56M | 1.56M | New | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2025-06-04 | P | A | 15,000 | $0.77 | 29,000 | D | — | — | (F1) The purchase was made in Euros and the price was converted into U.S. dollars based on the foreign currency exchange rate as of June 4, 2025 (at Euro 1.00 = U.S. dollar 1.1384). |
| 2 | Derivative | Stock Option | 2025-06-05 | A | A | 1,558,000 | $0.00 | 1,558,000 | D | $0.77 · — to 2035-06-05 | 1,558,000 Common Stock | (F3) 25% of the shares underlying the option vest on the first anniversary of the grant date, with the remainder vesting in equal increments on each successive one-month anniversary thereafter for the next 36 months. |